FOXO TECHNOLOGIES INC. Stock Repurchase Program, Authorized Amount
FOXO TECHNOLOGIES INC. (FOXO) had Stock Repurchase Program, Authorized Amount of $4.75 million as of 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramAuthorizedAmount1 · last filed 2024-01-19
- 2023-03-31: Stock Repurchase Program, Authorized Amount $4.75M.
- 2023-02-03: Stock Repurchase Program, Authorized Amount $4.75M.
- 2022-12-31: Stock Repurchase Program, Authorized Amount $62.00K.
- 2021-12-31: Stock Repurchase Program, Authorized Amount $65.00K.
| Period end | Stock Repurchase Program, Authorized Amount |
|---|---|
| 2023-03-31 | $4.75M 10-Q · filed 2023-05-11 |
| 2023-02-03 | $4.75M 10-Q · filed 2024-01-19 |
| 2022-12-31 | $62.00K 10-K · filed 2023-03-31 |
| 2021-12-31 | $65.00K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |